SpectraGenetics develops and supplies research tools for drug discovery and development, specializing in FAP-based platforms for measuring receptor internalization in living cells. The Pittsburgh company says it has made more than 350 plasmids expressing FAP-tagged human GPCRs and over 100 validated cell lines, and also offers GPCR assay kits and custom assay services.